… is inhibitory due to its allosteric actions at GABA A receptors, and based on the above
evidence that drugs that enhance GABA A receptor activity reduce dopamine release, we …

… the activity of the mesencephalic dopaminergic (DA) projection … measuring extracellular
concentrations of dopamine (DA) in … AlloP dose-dependently increased the release of DA in the …

… Turnover Rate in MBH and POA Allopregnanolone increased dopamine and dihydroxy…
In the MBH, allopregnanolone increased dopamine (p < 0.001) but showed a decrease in …

… EB treatment enhances stress-stimulated allopregnanolone levels and dopamine output in
adult … The persistent decrease in brain allopregnanolone concentrations, induced by neonatal …

… finasteride enhanced both maximal increase of dopamine and … These results suggest that
endogenous allopregnanolone … with potentiation of dopamine release induced by stress or by …

… , the levels of allopregnanolone are increased to normalize … develop against increased
allopregnanolone levels probably due … may result in variable release pattern of allopregnanolone. …

… is modulated by the activation of dopamine receptors. Using rodent models, we previously
reported that gating deficits caused by dopamine receptor activation - as measured by the …

… During estrus, amphetamineinduced striatal dopamine (DA) release is enhanced relative
to other days of the estrus cycle3,4. There is also estrous cycle-dependent variation in striatal …

… by peripheral nerve injury, the levels of ALLO are increased in the spinal cord, together with
… dopamine release from cortical dopaminergic neurones, 192 and prevents the dopamine …

… GABA is an inhibitory neurotransmitter, which is released from … ALLO reduces basal dopamine
level in the PFC and nucleus … of either ALLO or KSS improved anxious-like behaviors and …